In 1963, Roman Catholic fertility doctor John Rock published The Time Has Come: A Catholic Doctor's Proposals to End the Battle over Birth Control, a first-person treatise on the use of scientifically approved forms of birth control for Catholic couples. The first contraceptive pill, called Enovid, had been on the market since June 1960, and Rock was one of the leading researchers in its development. In The Time Has Come, Rock explicitly describes the arguments for and against the use of birth control from both a religious and a scientific perspective. With this work, he hoped to persuade the Roman Catholic Church that the use of a contraceptive pill was not contrary to Catholic natural law, which states that the primary function of marital sexual relations is to conceive a child. Rock lobbied for the acceptance and widespread use of contraceptive pills, which he considered to be of vital importance not only to women's reproductive health, but also to the struggle to control the world s burgeoning population.

The National Embryo Donation Center (NEDC) is a non-profit organization that was established in 2002 in Knoxville, Tennessee. The organization is endorsed and supported by several Christian-based associations such as the Christian Medical Association, Bethany Christian Services, and Baptist Health Systems. Its goal is to provide embryo donation and embryo adoption services in order to utilize the large number of embryos that are being cryopreserved as a result of infertility procedures and are no longer needed. Jeffrey Keenan, Medical Director of the NEDC, is an OB/GYN, reproductive endocrinologist, and infertility specialist.

Throughout history many different methods have been devised for the early detection of pregnancy. From the time of the Ancient Egyptians, inspection of the urine has been a popular place to start. However, it was not until the discovery of hormones in the early twentieth century that the development of truly reliable pregnancy tests occurred. Prior to 1978, when the first home pregnancy tests became available in the United States, pregnancy testing was done in hospital laboratories using various methods, one of them being the Aschheim-Zondek, or A-Z test.

José Pedro Balmaceda was born 22 August 1948 in Santiago, Chile. His mother Juanita owned a women's boutique in the city and his father José was a successful owner of several timber mills. He grew up with five sisters who remained in Santiago all their lives. Balmaceda attended the college preparatory school San Ignatius where he met Sergio Stone, his future partner at the Center for Reproductive Health fertility clinic in the University of California Irvine Medical Center. In 1974 Balmaceda graduated from Catholic University Medical School and became a resident at the University of Chile hospital where he worked in obstetrics and gynecology.

In September 1979, China's Fifth National People's Congress passed a policy that encouraged one-child families. Following this decision from the Chinese Communist Party (CCP), campaigns were initiated to implement the One-Child Policy nationwide. This initiative constituted the most massive governmental attempt to control human fertility and reproduction in human history. These campaigns prioritized reproductive technologies for contraception, abortion, and sterilization in gynecological and obstetric medicine, while downplaying technologies related to fertility treatment. In the late 1980s, one of the consequences was the reorientation of the rationality of governmental funding for research on human in vitro fertilization (IVF) and embryo transfer.

Sergio Cereceda Stone was born 16 April 1942 in the coastal city of Valparaiso, Chile. Stone's mother Luz was a housewife and caretaker for Sergio and his younger brother Lionel; his father Sergio served among the country's twenty appellate court judges. In the early 1950s Stone's father relocated the family to Santiago to further his law career. There Stone attended the Jesuit elementary and high school Collegio San Ignatius, finished in the top ten percent of his class, and met José Balmaceda, his future coworker at the Center for Reproductive Health in Irvine, California. From San Ignatius, Stone went on to the University of Chile Medical School where he finished his obstetrics and gynecology residency. In 1969 he accepted a grant from the Ford Foundation for advanced research in endocrinology.

Jeffrey Keenan is the Director of the Southeastern Center for Fertility and Reproductive Medicine and the main developer behind the National Embryo Donation Center (NEDC) in Knoxville, Tennessee. This non-profit organization focuses on embryo donation and embryo adoption.

Ricardo Hector Asch was born 26 October 1947 in Buenos Aires, Argentina, to a lawyer and French professor, Bertha, and a doctor and professor of surgery, Miguel. Asch's middle-class family lived among the largest Jewish community in Latin America, where a majority of males were professionals. After his graduation from National College No. 3 Mariano Moreno in Buenos Aires, Asch worked as a teaching assistant in human reproduction and embryology at the University of Buenos Aires School of Medicine where he received his medical degree in 1971.

David Wildt's cheetah (Acinonyx jubatus) research from 1978-1983 became the foundation for the use of embryological techniques in endangered species breeding programs. The cheetah is a member of the cat family (Felidae), which includes thirty-seven species. According to the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES) all Felidae species are currently threatened or endangered, with the exception of the domestic cat (Felinus catus). Cheetahs are an internationally recognized charismatic megafauna species, prized zoo specimens, difficult to breed, and the basis of many conservation campaigns. Like most species, cheetahs have not traditionally been studied; only a few "model" organisms have been thoroughly researched in a laboratory setting. This research revealed that the difficulty observed in breeding cheetahs in captivity is due to their lack of genetic diversity.

In 2021, the World Health Organization, or WHO, published the sixth edition of their Laboratory Manual for the Examination and Processing of Human Semen, which provides standardized guidelines to physicians and other medical professionals performing semen analysis. Semen analysis is a technique that medical professionals use to analyze the characteristics of a male’s semen and sperm cells to identify possible causes of male infertility. A sperm cell is the male sex cell that fertilizes a female’s egg cell, while semen is the fluid containing sperm cells that men release during ejaculation. The WHO created the first laboratory manual for semen analysis in 1980, a time when there was no standardized way to analyze a male’s semen sample. The WHO laboratory manual was one of the first documents to standardize a procedure for evaluating human semen to look for sperm abnormalities, and it remains one of the most widespread methods of evaluating a male’s fertility potential and determining the causes of male infertility.